Cancer of the Prostate study: TEMPO
Official title A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers
ClinicalTrials.gov ID: NCT06363266
What this study is testing
- What it's testing
- The study wants to find out if using TEMPO improves health and reduces anxiety for men with prostate cancer and their caregivers. It also looks at the cost and overall impact of the program.
- Who it's for
- Men who have prostate cancer and their family or friends who help them care for them.
- What's involved
- Participants are randomly put into one of two groups: one uses the TEMPO web program, the other only monitors their anxiety for 12 weeks. All participants fill out surveys to track changes in health and anxiety. Those who need extra help may get additional support after the 12‑week period.
- Time commitment
- The study lasts 12 weeks. Participants will complete surveys during that time and may receive extra support if needed.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient Prostate cancer diagnosis; Treatment for prostate cancer (excluding active surveillance) scheduled to start or received within the past 2...
- Caregiver Are nominated by patient as primary support person; Are patients' spouse, partner, or other family member
You likely can't join if
- for patient and caregiver: Hospitalized
The study team makes the final eligibility decision.
Where it is enrolling
- Montreal, Canada, Canada
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Montreal, Canada, Canada; Montreal, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.